← Back
$VIR All transactions

Vir Biotechnology, Inc.

▼ SELL 10b5-1 Plan

$ Value

$16K

Shares

2,089

Price

$7

Filed

Feb 24

Insider

Name

O'Byrne Jason

Title

EVP & Chief Financial Officer

CIK

0001871145

Roles

Officer

Transaction Details

Transaction Date

2026-02-23

Code

S

Table

Non-Derivative

Ownership

Direct

Equity Swap

No

Shares After

164,249

Footnotes

Acquisition of restricted stock units (RSUs) pursuant to the Issuer's Equity Incentive Plan. | Includes 637 shares of common stock acquired by the Reporting Person on November 28, 2025, pursuant to an employee stock purchase program. | Represents an automatic and mandatory sale of shares under a Rule 10b5-1 arrangement to satisfy the Issuer's tax withholding obligations in connection with the vesting of RSUs. The sale does not represent a discretionary trade by the Reporting Person. | 25% of the shares subject to the stock option will vest and become exercisable on February 22, 2027, and the remaining shares will vest in 36 equal monthly installments thereafter.

Filing Info

Accession No.

0001628280-26-011330

Form Type

4

Issuer CIK

0001706431

O'Byrne Jason's History

Date Ticker Type Value
2026-02-24 VIR $16K
2026-02-23 VIR $16K
2026-02-22 VIR A $0
2026-02-22 VIR A $0
2025-11-17 VIR $38K

Other Insiders at VIR (90d)

Insider Bought Sold Last
SATO VICKI L $992K 2026-04-01
De Backer Marianne
Chief Executive Officer
$283K 2026-02-24
De Backer Marianne
President and CEO
$664K 2026-04-06
Eisner Mark
EVP and Chief Medical Officer
$50K 2026-02-25
O'Byrne Jason
EVP & Chief Financial Officer
$16K 2026-02-24
de Verneuil Vanina
EVP, General Counsel, Corp Sec
$197K 2026-02-25
Sabatini Brent
SVP, Chief Accounting Officer
$110K 2026-03-23